- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00823784
Prospective Randomized Trial Comparing THD Versus Stapler Operation for 3rd Degree Hemorrhoids (THD/stapler)
January 15, 2009 updated by: Societa Italiana di Chirurgia ColoRettale
Prospective Randomized Trial Comparing Transanal Doppler de-Arterialization (THD) Versus Stapler Operation for 3rd Degree Hemorrhoids
Haemorrhoids have, in literature, extremely high ranges of prevalence, 4,4% to 36% and there is a debate on the best treatment for III degree hemorrhoids.
The Stapled Hemorrhoidopexy is indicated in grade III haemorrhoids due to its advantages vs. other techniques in pain reduction and time before resume of normal activity.
The new technique of Doppler guided trans-anal arterial ligation (THD) appear to be another important therapeutic tool thanks to its scarce complications, the minimally invasive procedure and efficacy of the short term results.
The rationale of the two surgical techniques is different: in fact, the Stapled Hemorrhoidopexy is based on the hypothesis that the mucosal and sub/mucosal resection and stapling can cure the prolapse, etiologic factor of haemorrhoids; on the other hand, the interruption of the arterial inflow of hemorrhoids by THD reduces hemorrhoidal tissue."
Aim of this study is to compare 2 techniques: The doppler guided transanal haemorrhoidal dearterialisation with the THD device and the stapled Haemorrhoidopexy (according to Longo) for III degree (Goligher) haemorrhoid, not regarding the number of prolapsed piles
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
After informed consent 284 patients with III degree hemorrhoids from 10 colorectal units will be randomized into two groups: stapler vs doppler guided transanal hemorrhoidal dearterialisation with the THD device.The early and long term outcome, as well as other secondary outcomes (costs, return to work and degree of satisfaction) will be recorded and compared.
Study Type
Interventional
Enrollment (Anticipated)
270
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Aldo Infantino, MD
- Phone Number: ++39 3356862961
- Email: ainfantino@libero.it
Study Locations
-
-
PN
-
S Vito al Tagliamento, PN, Italy, 33078
- Recruiting
- Santa Maria dei Battuti Hospital
-
Contact:
- Aldo Infantino, MD
- Phone Number: ++39 3356862961
- Email: ainfantino@libero.it
-
Principal Investigator:
- Aldo Infantino, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- III degree hemorrhoids
- both sex
- age between 18 and 70 years
- ability to understand the procedure
- written informed consent
Exclusion Criteria:
- previous surgery for hemorrhoids
- fecal incontinence
- obstructed defecation
- other active anorectic diseases
- irritable bowel syndrome
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: 1THD group
Series of 135 patients with 3rd degree Hemorrhoids treated by THD device under spinal anaesthesia
|
THD technique involves identification and ligation of the terminal hemorrhoid arteries (about 6) followed by mucopexy
Other Names:
|
ACTIVE_COMPARATOR: 2 stapler group
135 patients with 3rd degree hemorrhoids will be treated by staple hemorrhoidopexy
|
Staple hemorrhoidopexy involves resection of a ring of low rectal mucosa an lifting the hemorrhoids up in the anal canal with a stapled suture
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
early complication rate (bleeding, pain) and long term outcome (symptomatic hemorrhoids recurrence) after stapled hemorrhoidopexy versus transanal hemorrhoid arteries ligation and mucopexy
Time Frame: early postoperative period (30 days) and after 1 year
|
early postoperative period (30 days) and after 1 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Time to return to the working activities, costs for the public health system and the degree of patients' satisfaction
Time Frame: early postoperative period
|
early postoperative period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Chair: Donato F Altomare, MD, Societa Italiana di Chirurgia ColoRettale
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2008
Primary Completion (ANTICIPATED)
January 1, 2009
Study Completion (ANTICIPATED)
July 1, 2009
Study Registration Dates
First Submitted
January 15, 2009
First Submitted That Met QC Criteria
January 15, 2009
First Posted (ESTIMATE)
January 16, 2009
Study Record Updates
Last Update Posted (ESTIMATE)
January 16, 2009
Last Update Submitted That Met QC Criteria
January 15, 2009
Last Verified
January 1, 2009
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Siccr trial THD/stapler
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hemorrhoids
-
Vilnius UniversityBiolitec Pharma Ltd.UnknownHemorrhoids Second Degree | Hemorrhoids Third DegreeLithuania
-
Ventrus Biosciences, IncTerminatedInternal HemorrhoidsUnited States
-
Societa Italiana di Chirurgia ColoRettaleSICCR - Gaetano GalloCompletedSecond-degree HemorrhoidsItaly
-
Medtronic - MITGCompletedHemorrhoids, InternalUnited States
-
The Second Affiliated Hospital of Hunan University...Hunan University of Traditional Chinese Medicine; Zhengfeng Medical Technology...Unknown
-
Universitätsklinikum Hamburg-EppendorfCompletedInternal Hemorrhoids
-
Nivagen Pharmaceuticals Inc.CompletedInternal HemorrhoidsUnited States, India
-
Universidade do PortoCompletedHemorrhoids, InternalPortugal
-
G & W Laboratories Inc.CompletedInternal HemorrhoidsUnited States
-
Kuwait Oil Company Ahmadi HospitalNetherlands: Ministry of Health, Welfare and SportsCompleted
Clinical Trials on Transanal doppler hemorrhoidal ligation
-
University Hospital, AkershusTerminatedSymptomatic Haemorrhoidal DiseaseNorway
-
Russian Society of Colorectal SurgeonsUnknown
-
Federal University of AmazonasUnknownSecond-degree HemorrhoidsBrazil
-
Cantonal Hospital of St. GallenActive, not recruitingHemorrhoidsSwitzerland
-
Universitair Ziekenhuis BrusselNot yet recruiting
-
Hospital Universitari de BellvitgeCompleted
-
Universidade do PortoCompleted
-
Societa Italiana di Chirurgia ColoRettaleUnknown
-
Centre Hospitalier Departemental VendeeRecruitingHaemorrhoids | Internal Haemorrhoids | Grade II/III HaemorrhoidsFrance